Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy

NCT04333004 is registered in ClinicalTrials.gov with Xiaorong Dong as lead sponsor.

NCT NCT04333004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04333004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy
Lead sponsor
Xiaorong Dong
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 30, 2020
Completion date
April 30, 2022
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy, gut microbiota, nsclc, pembrolizumab